Everstone Acquires Majority Stake in Rubicon Research

-
by Suman Gupta

Mumbai, October 24, 2016 : The Everstone Group has bought a 70% stake in Mumbai-based Rubicon Research Pvt. Ltd., a pioneering drug delivery technology company in India, for a total outlay of Rs 220 crore (US$ 33 million). Along with a US$ 20 million investment directly into the business, the deal includes acquiring stakes from Kotak Private Equity and a private investor. Rubicon is a world-class outsourcing partner to the global pharmaceutical industry and its proprietary technologies provide solutions for bioavailability enhancement, gastric retention, taste masking, and customising the release profiles of drugs. Rubicon also offers lifecycle management services for pharmaceutical products. Rubicon also has a US FDA-approved manufacturing plant at Ambernath in Maharashtra, with a capacity of 800 million tablets and it has refocused its business on creating its own Abbreviated New Drug Applications (ANDAs)/New Drug Applications (NDAs) for the global market. “Rubicon has an excellent record of providing cutting-edge solutions to the healthcare and pharmaceutical industry,” said Sameer Sain, Co-Founder and Managing Partner of the Everstone Group. “We are excited about enhancing its capabilities,” Sameer added. Rubicon Founder and CEO Dr. Pratibha Pilgaonkar said: “We welcome this partnership with Everstone and believe, with their deep managerial and operational expertise, capital infusion, and global connectivity, we will be able to significantly accelerate our growth.” This investment will be fourth investment from Everstone’s latest PE fund (Everstone Capital Partners III) and was led by Deep Mishra, an Everstone MD who focuses on consumer and pharmaceutical investments for the Group. Deep will be joining the board of directors of Rubicon. 

About Everstone Group The Everstone Group is a premier India and Southeast Asia focused private equity and real estate investment firm with assets under management of USD $3.3 billion. Headquartered in Singapore, Everstone has around 200 people working across five offices—Singapore, Mumbai, Delhi, Bengaluru, and Mauritius. Everstone has been awarded ‘Private Equity Firm of the Year in India’ by Private Equity International for five consecutive years. 

About Rubicon Rubicon Research is a pioneer Drug Delivery Technology company in India and is recognized as a world class outsourcing partner in pharmaceutical industry. Rubicon’s proprietary technologies provide solutions for bioavailability enhancement, gastric retention, taste masking, and customising the release profiles. Rubicon has a US FDA-approved manufacturing plant and is bringing complex generics into the regulated markets of US and Europe. For more information, visit http://www.rubicon.co.in/

Comments

Post a Comment

Popular posts from this blog

KERALA TOURISM WOOS TOURISTS

-
Image
Kerala Tourism attracts more tourists with new initiatives! Explore God’s Own Canvas! by Priya Jadhav Mumbai, 07th February, 2017: Considering the uptick in inbound tourism from Mumbai, the Department of Tourism, Government of Kerala is organizing B2B Roadshows in Mumbai on 07th  February, 2017. The roadshow desires to attract city’s leading travel agents and tour operators, and showcase to them the best of ‘God’s own country’. The delegation from Kerala is led Mr Shine KS - Tourist Information Officer, Department of Tourism, Govt of Kerala and will comprise major players from the state’s Tourism & Trade industry. Besides forging fresh collaborations, the roadshow will introduce new initiatives, experiences and attractions that Kerala has in store for visitors. Kerala Tourism: The story so far… The Marketing Initiatives for the year 2016-17 were formulated and executed based on the keen understanding of the unique appeal that 'God's Own Countr
Read more

Excellent Classes organises 34th edition of HUES, felicitates its meritorious students

-
Image
by Priya Jadhav  Mumbai, 2 nd  January 2024:   Excellent Classes,   a pioneer coaching institute in Mumbai   organised its 34 th   Annual Program called HUES - Honouring Unique & Excellent Students, where the institute rewarded the hard work and achievement of its students for the year 2023. Dr. Zaibunnisa Malik, an educationist and social activist working for the upliftment of underprivileged children graced the occasion as the Guest of Honour.     Briefing about HUES, Dr. Jamil Khan, Director of Excellent Classes  informed, “At HUES, we celebrate the performance of our students who performed exceptionally well in their Boards and Entrance exams like – ICSE, SSC, NEET, etc. The students have been working very hard for these exams and this is a way to celebrate and acknowledge their hard work.”  Students who were felicitated at the program are - Mahi Naik secured 95.6% in SSC and stood first in the institute. Asma Sayed secured 89.67% in HSC Science and also secured 99.27 percentil
Read more

Haier Launches Inverter Expert Air Conditioner Series - A New Dawn in Air Conditioning

-
Image
· Introducing a range of inverter ACs with energy saving and instant   cooling capabilities · Designed for the internet generation with WiFi and 1 touch LED      system by Suman Gupta New Delhi, March 29, 2017: Haier, the global leader in Home Appliances & Consumer Electronics and  World’s Number 1 brand in Major Appliances for the 8th Consecutive Year*, recently announced the launch of its Dawn air conditioners along with a series of other air conditioners. The air conditioners have been introduced and designed particularly taking inspiration from the needs and requirements of the consumers and keeping in mind the weather conditions of the country. The launch is aimed at maintaining Haier’s position as a leader in the industry, specifically in the segment of air conditioners and provides consumers with a wide variety of products in the category. The new lineup of air conditioners comes with inverter technology resulting in electricity saving capabilities
Read more